ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
Conditions
- Atherosclerotic Cardiovascular Disease
Interventions
- DRUG: Alirocumab
- DRUG: Placebo
- DRUG: LMT
Sponsor
Sanofi
Collaborators